Changes in Secondary Outcomes of Energy Intake, Body Composition, and Glucose, Insulin, and Blood Pressure, by Group
pandemic).Weight loss, Weight loss, weight loss, hypertensive
SI conversion factors: To convert glucose to millimoles per liter, multiply by 0.0555; high-density lipoprotein cholesterol to millimoles per liter, multiply by 0.0259; insulin to picomoles per liter, multiply by 6.945.All models were adjusted for baseline socioeconomic status (education and employment), food security status, sex, age, and use of medications that may impact the examined outcome. For glucose and insulin outcomes, use of diabetes-related medications at the examined time point were included in the model. For blood pressure, use of hypertensive medications at the examined time point were included in the model.Primary outcomes occurred at the 12-month assessment measure.Because of the COVID-19 pandemic, body circumference measures were not taken after the 6-month assessments (which were all conducted prior to the pandemic).Weight loss that occurred in cohort 1 (67 participants) was compared with weight loss that occurred in cohort 2 (92 participants). Weight loss did not differ at 3 months (mean, cohort 1 vs cohort 2, –1.65 kg [95% CI, –2.76 to –0.53 kg] vs –1.56 kg [95% CI, –2.50 to –0.62 kg]; 